• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Salix Pharmaceuticals Ltd. (SLXP)

    -NasdaqGS
    117.20 1.25(1.06%) Dec 19, 4:00PM EST
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.3
    Mean Recommendation (last week):2.3
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:126.56
    Median Target:125.00
    High Target:185.00
    Low Target:95.00
    No. of Brokers:16

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Nov 7, 2014ROTH CapitalDowngradeBuyNeutral
    Nov 7, 2014StifelDowngradeBuyHold
    Nov 7, 2014MizuhoDowngradeBuyNeutral
    Jun 27, 2014Canaccord GenuityInitiated Buy
    Mar 18, 2014National Alliance SecuritiesInitiated Buy
    Dec 17, 2013StifelUpgradeHoldBuy
    Aug 5, 2013Cantor FitzgeraldDowngradeBuyHold
    Jan 11, 2013RBC Capital MktsInitiated Outperform
    Nov 30, 2012MizuhoInitiated Buy
    Aug 9, 2012Cantor FitzgeraldUpgradeHoldBuy

    More Upgrades & Downgrades for SLXP

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0476
    Buy0466
    Hold0965
    Underperform0001
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.